Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Antonio Rueda, David Olmos, Luis Vicioso, Cristina Quero, Elena Gallego, Bella Isabel Pajares-Hachero, Marta Mendiola, María Casanova, Martina Álvarez, Mariano Provencio & Emilio Alba. (2015) Role of vascular endothelial growth factor C in classical Hodgkin lymphoma. Leukemia & Lymphoma 56:5, pages 1286-1294.
Read now
Read now
Antonio Rueda, Julio Rifá, Cristina Quero, José Gómez-Codina, Adolfo Murias, Francisco Ramón García-Arroyo, Pilar Sabín, Marta Llanos, Joaquin Herrero, Francisco Lobo, Juan Ramón Delgado & Mariano Provencio. (2014) High serum levels of vascular endothelial growth factor-C have a positive impact on outcome of patients with advanced diffuse large B cell lymphoma. Leukemia & Lymphoma 55:6, pages 1413-1416.
Read now
Read now
Maria B. Karpova, Kazuyasu Fujii, Daniella Jenni, Reinhard Dummer & Mirjana Urosevic-Maiwald. (2011) Evaluation of lymphangiogenic markers in Sézary syndrome. Leukemia & Lymphoma 52:3, pages 491-501.
Read now
Read now
Dita Gratzinger. (2009) VEGF-C: putting the ‘lymph’ back in lymphoma?. Leukemia & Lymphoma 50:3, pages 311-312.
Read now
Read now
Articles from other publishers (17)
Eko Pangarsa, Probo Wuryantoro, Ridho Naibaho, Budi Setiawan, Damai Santosa, Hermawan Istiadi, Dik Puspasari & Catharina Suharti. (2022) Preliminary study of hypoxia markers in diffuse large B‑cell lymphoma. Molecular and Clinical Oncology 17:3.
Crossref
Crossref
. 2022. Genesis, Pathophysiology and Management of Venous and Lymphatic Disorders. Genesis, Pathophysiology and Management of Venous and Lymphatic Disorders
461
481
.
Lutz Menzel, Uta E. Höpken & Armin Rehm. (2020) Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth. Frontiers in Immunology 11.
Crossref
Crossref
Chieh-Lung Cheng, Yung-Cheng Su, Tsu-Yi Chao, Chung-Wu Lin, Sheng-Chieh Chou, Ming Yao, Sung-Hsin Kuo & Shan-Chi Yu. (2018) Intralymphatic Spread is a Rare Finding Associated With Poor Prognosis in Diffuse Large B-Cell Lymphoma With Extranodal Involvements. American Journal of Surgical Pathology 42:5, pages 616-624.
Crossref
Crossref
W.J. Lee, Y.J. Kim, Y.J. Lee, C.H. Won, S.E. Chang, J.H. Choi & M.W. Lee. (2017) Vascular endothelial growth factor protein expression is associated with a poor prognosis in patients with cutaneous extranodal natural killer/T‐cell lymphoma. British Journal of Dermatology 178:1.
Crossref
Crossref
Rebeca Ridings-Figueroa, Emma R. Stewart, Tatyana B. Nesterova, Heather Coker, Greta Pintacuda, Jonathan Godwin, Rose Wilson, Aidan Haslam, Fred Lilley, Renate Ruigrok, Sumia A. Bageghni, Ghadeer Albadrani, William Mansfield, Jo-An Roulson, Neil Brockdorff, Justin F.X. Ainscough & Dawn Coverley. (2017) The nuclear matrix protein CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory. Genes & Development 31:9, pages 876-888.
Crossref
Crossref
Jing Yang, Wenlu Li, Xin He, Guofei Zhang, Lan Yue & Ying Chai. (2015) VEGF Overexpression Is a Valuable Prognostic Factor for Non-Hodgkin’s Lymphoma Evidence from a Systemic Meta-Analysis. Disease Markers 2015, pages 1-9.
Crossref
Crossref
Konstantin YakimchukMohammad Sharif HasniJiyu GuanMark P. Chao, Birgitta Sander & Sam Okret. (2014) Inhibition of lymphoma vascularization and dissemination by estrogen receptor β agonists. Blood 123:13, pages 2054-2061.
Crossref
Crossref
Hilmar Quentmeier, Sonja Eberth, Julia Romani, Herbert A Weich, Margarete Zaborski & Hans G Drexler. (2012) DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4). BMC Cancer 12:1.
Crossref
Crossref
Sahar F.M. Mansour & Hala A.D. Mohamed. (2012) The prognostic impact of microvessel density using angiogenic markers (CD105 and CD34) on patients with diffuse large B-cell lymphoma. Egyptian Journal of Pathology 32:2, pages 268-273.
Crossref
Crossref
SHU-PEI MA, MEI LIN, HAI-NING LIU & JIAN-XIAN YU. (2012) Lymphangiogenesis in non-Hodgkin’s lymphoma and its correlation with cyclooxygenase-2 and vascular endothelial growth factor-C. Oncology Letters 4:4, pages 695-700.
Crossref
Crossref
C Cocco, E Di Carlo, S Zupo, S Canale, A Zorzoli, D Ribatti, F Morandi, E Ognio & I Airoldi. (2011) Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo. Leukemia 26:6, pages 1365-1374.
Crossref
Crossref
Jürgen Becker, Ana Covelo-Fernandez, Frederike von Bonin, Dieter Kube & Jörg Wilting. (2012) Specific tumor-stroma interactions of EBV-positive Burkitt's lymphoma cells in the chick chorioallantoic membrane. Vascular Cell 4:1, pages 3.
Crossref
Crossref
Wosztyl Anna, Wołowiec Dariusz, Ziółkowska Ewelina, Robak Ewa & Korycka-Wołowiec Anna. (2012) Osoczowe stężenie cytokin limfo-i angiogennych u chorych na chłoniaka rozlanego z dużych komórek B. Acta Haematologica Polonica 43:3, pages 277-284.
Crossref
Crossref
Semra Paydas. (2010) Anti-angiogenic strategies will be a revolution in lymphoma?. Leukemia Research 34:4, pages 552.
Crossref
Crossref
Semra Paydas, Melek Ergin, Gulsah Seydaoglu, Seyda Erdogan & Sinan Yavuz. (2009) Pronostic significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature. Leukemia Research 33:12, pages 1627-1635.
Crossref
Crossref
Jason R. Westin & Luis E. Fayad. (2009) Beyond R-CHOP and the IPI in large-cell lymphoma: Molecular markers as an opportunity for stratification. Current Hematologic Malignancy Reports 4:4, pages 218-224.
Crossref
Crossref